Hematologic Cancer Develops in Some Patients Receiving Eli-Cel
Hematologic cancer developed in seven of 67 patients with cerebral adrenoleukodystrophy receiving eli-cel gene therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.